$B0fF#!!>4!JL>8E20Bg3X!K(B |
$B:F@80eNE$d93BN0eLt$N@8;:!"@8BNLOJo%7%9%F%`$NH/E8$J$I$K6aG/$N2=3X9)3X$OBg$-$/9W8%$7$F$-$^$7$?!#K\%7%s%]%8%&%`$G$O!">-Mh$N0eNE$dAOLt$NH/E8$K9W8%$9$k?75;=Q$K4X$9$k0lHL1iBj$rJg=8$7!":G?7$N8&5f@.2L$K$D$$$F3hH/$K5DO@$9$k$3$H$rL\E*$H$7$^$9!#(B
$B:G=*99?7F|;~!'(B2022-01-31 16:50:01
$B$3$NJ,N`$G$h$/;H$o$l(B $B$F$$$k%-!<%o!<%I(B | $B%-!<%o!<%I(B | $B | |
---|---|---|---|
Biomedical application | 1$B7o(B | ||
cancer treatment | 1$B7o(B | ||
iPS cells | 1$B7o(B | ||
enzymatic post-modification | 1$B7o(B | ||
Lipid Membrane | 1$B7o(B | ||
i-motif | 1$B7o(B | ||
B cell lymphoma | 1$B7o(B | ||
Nucleic Acid | 1$B7o(B | ||
cooperative effect | 1$B7o(B | ||
Cationic | 1$B7o(B | ||
cell differentiation | 1$B7o(B | ||
3D bioprinting | 1$B7o(B | ||
microfluidic device | 1$B7o(B | ||
protein-protein interaction | 1$B7o(B | ||
vaccine | 1$B7o(B | ||
peritoneal injury | 1$B7o(B | ||
three-dimensional culture | 1$B7o(B | ||
phospholipid polymers | 1$B7o(B | ||
biopharmaceutical | 1$B7o(B | ||
3D culture | 1$B7o(B | ||
Bioprinting | 1$B7o(B | ||
redox reactions | 1$B7o(B | ||
Shear-induced structure | 1$B7o(B | ||
signal transduction | 1$B7o(B | ||
lipid bilayer | 1$B7o(B | ||
Crosslinked film | 1$B7o(B | ||
host cell | 1$B7o(B | ||
porous scaffold | 1$B7o(B | ||
Aqueous two-phase system | 1$B7o(B | ||
Cell sheets | 1$B7o(B | ||
antibody screening | 1$B7o(B | ||
CHL-YN | 1$B7o(B |
$B | $B9V1iBjL\!?H/I=$B%-!<%o!<%I(B | $BH/I=7A<0(B | |
---|---|---|---|
178 | $BKl6I:_$K$h$kA}?#%7%0%J%k$r;XI8$H$7$?:YK&FbCAGr | protein-protein interaction signal transduction antibody screening | O |
231 | $B%l%I%C%/%9%j%s;i | cancer treatment redox reactions phospholipid polymers | O |
232 | $B9bA}?#@-?75,@8;:=I | CHL-YN host cell biopharmaceutical | O |
239 | $B936]Lt3+H/$K8~$1$?936]%Z%W%A%I!&%@%V%k%3%*%Z%i%F%#%V8z2L$N86M}2rL@(B | antimicrobial peptide cooperative effect lipid bilayer | O |
318 | $BCf6u;e$rMQ$$$?(BiPS$B:YK&$NA}?#$HFbfuMUJ,2=M6F3(B | iPS cells three-dimensional culture cell differentiation | O |
325 | 3D$B%P%$%*%W%j%s%F%#%s%0$K$h$k?e@-FsAj7O%$%s%/$rMQ$$$?%R%I%m%2%k%U%!%$%P!<$N:n@=(B | 3D bioprinting Aqueous two-phase system Shear-induced structure | O |
344 | $B%?%s%Q%/~$,2DG=$J<+8JAH?%2=%Z%W%A%I%U%!%$%P!<$NAO@=$H%o%/%A%s$X$NE83+(B | Self-assembled peptide enzymatic post-modification vaccine | O |
576 | $B%^%$%/%mN.BN%G%P%$%9$rMQ$$$?5$K"$r9&8;$H$9$kB?9& | Bioprinting microfluidic device porous scaffold | O |
753 | Cationic crosslinked film, by modified Poly(vinyl alcohol) and dextran for biomedical applications | Cationic Crosslinked film Biomedical application | O |
771 | $BHsI8=`9=B$$rM-$9$k(Bi-motif$B3K;@$H;i | i-motif Lipid Membrane Nucleic Acid | O |
870 | $BJ"Kl=}322~A1$X$N:YK&%7!<%H9)3X$+$i$N%"%W%m!<%A(B | Cell sheets peritoneal injury | O |
873 | B$B:YK&%j%s%Q
| B cell lymphoma 3D culture | O |